IVL3001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for IVL3001, covering 2022-03-04 to 2022-03-04. Get the full timeline:
Most recent: Clinical Trial Update: A Clinical Trial to Assess Pharmacokinetic/Pharmacodynamic Profiles and Safety of IVL3001 [Phase 1, Phase 2]